These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 6295786)
1. Characterization of [3H]nifedipine binding sites in rabbit myocardium. Holck M; Thorens S; Haeusler G Eur J Pharmacol; 1982 Dec; 85(3-4):305-15. PubMed ID: 6295786 [TBL] [Abstract][Full Text] [Related]
2. Does [3H]nifedipine label the calcium channel in rabbit myocardium? Holck M; Thorens S; Haeusler G J Recept Res; 1983; 3(1-2):191-8. PubMed ID: 6304296 [TBL] [Abstract][Full Text] [Related]
3. Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites. Bristow MR; Ginsburg R; Laser JA; McAuley BJ; Minobe W Br J Pharmacol; 1984 Jun; 82(2):309-20. PubMed ID: 6329392 [TBL] [Abstract][Full Text] [Related]
4. Nifedipine, diltiazem, bepridil and verapamil uptakes into cardiac and smooth muscles. Pang DC; Sperelakis N Eur J Pharmacol; 1983 Feb; 87(2-3):199-207. PubMed ID: 6601581 [TBL] [Abstract][Full Text] [Related]
5. Interaction of the calcium channel activating 3H-BAY K 8644 and inhibiting 3H-verapamil with specific receptor sites on cultured beating myocardial cells. Bellemann P J Recept Res; 1984; 4(1-6):571-85. PubMed ID: 6084713 [TBL] [Abstract][Full Text] [Related]
6. Comparison of negative inotropic potency, reversibility, and effects on calcium influx of six calcium channel antagonists in cultured myocardial cells. Barry WH; Horowitz JD; Smith TW Br J Pharmacol; 1985 May; 85(1):51-9. PubMed ID: 4027472 [TBL] [Abstract][Full Text] [Related]
7. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle. Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393 [TBL] [Abstract][Full Text] [Related]
8. Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heart. Ferry DR; Glossmann H; Kaumann AJ Br J Pharmacol; 1985 Apr; 84(4):811-24. PubMed ID: 2408698 [TBL] [Abstract][Full Text] [Related]
9. Slow calcium channel blockers and the calcium paradox: comparative studies in the rat with seven drugs. Baker JE; Hearse DJ J Mol Cell Cardiol; 1983 Jul; 15(7):475-85. PubMed ID: 6312058 [TBL] [Abstract][Full Text] [Related]
10. The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats. Ehlert FJ; Roeske WR; Itoga E; Yamamura HI Life Sci; 1982 Jun; 30(25):2191-202. PubMed ID: 7109844 [TBL] [Abstract][Full Text] [Related]
11. Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecificity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphates. Galizzi JP; Fosset M; Lazdunski M Eur J Biochem; 1984 Oct; 144(2):211-5. PubMed ID: 6092067 [TBL] [Abstract][Full Text] [Related]
12. The interaction of phenylalkylamine calcium channel blockers with the 1,4-dihydropyridine binding site. Zobrist RH; Giacomini KM; Nelson WL; Giacomini JC J Mol Cell Cardiol; 1986 Sep; 18(9):963-74. PubMed ID: 3783730 [TBL] [Abstract][Full Text] [Related]
13. A calcium antagonist drug binding site in skeletal muscle sarcoplasmic reticulum: evidence for a calcium channel. Fairhurst AS; Thayer SA; Colker JE; Beatty DA Life Sci; 1983 Mar; 32(12):1331-9. PubMed ID: 6300579 [TBL] [Abstract][Full Text] [Related]
14. Relationship of binding of a calcium channel blocker to inhibition of contraction in intact cultured embryonic chick ventricular cells. Marsh JD; Loh E; Lachance D; Barry WH; Smith TW Circ Res; 1983 Oct; 53(4):539-43. PubMed ID: 6313249 [TBL] [Abstract][Full Text] [Related]
15. Interaction of AOA 39, D600, verapamil and diltiazem with cardiac cholinergic effects. Mubagwa K; Carmeliet E Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):71-84. PubMed ID: 3592862 [TBL] [Abstract][Full Text] [Related]
16. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms. Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175 [TBL] [Abstract][Full Text] [Related]
17. Differentiation of receptor sites for [3H]nitrendipine in chick hearts and physiological relation to the slow Ca2+ channel and to excitation-contraction coupling. Renaud JF; Kazazoglou T; Schmid A; Romey G; Lazdunski M Eur J Biochem; 1984 Mar; 139(3):673-81. PubMed ID: 6321185 [TBL] [Abstract][Full Text] [Related]
18. High affinity binding sites for [3H]-nitrendipine in rabbit uterine smooth muscle. Miller WC; Moore JB Life Sci; 1984 Apr; 34(18):1717-24. PubMed ID: 6727544 [TBL] [Abstract][Full Text] [Related]
19. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644. Janis RA; Sarmiento JG; Maurer SC; Bolger GT; Triggle DJ J Pharmacol Exp Ther; 1984 Oct; 231(1):8-15. PubMed ID: 6208356 [TBL] [Abstract][Full Text] [Related]
20. Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain. Schoemaker H; Boles RG; Roeske WR; Yamamura HI Proc West Pharmacol Soc; 1983; 26():219-24. PubMed ID: 6310626 [No Abstract] [Full Text] [Related] [Next] [New Search]